stoxline Quote Chart Rank Option Currency Glossary
Helius Medical Technologies, Inc. (HSDT)
6.34  -0.02 (-0.31%)    11-28 13:28
Open: 6.34
High: 6.5
Volume: 1,088
Pre. Close: 6.36
Low: 6.34
Market Cap: 4(M)
Technical analysis
2023-11-28 1:48:12 PM
Short term     
Mid term     
Targets 6-month :  8.51 1-year :  9.25
Resists First :  7.29 Second :  7.92
Pivot price 6.67
Supports First :  6.28 Second :  5.22
MAs MA(5) :  6.5 MA(20) :  6.94
MA(100) :  8.21 MA(250) :  10.67
MACD MACD :  -0.4 Signal :  -0.4
%K %D K(14,3) :  13 D(3) :  16.4
RSI RSI(14): 39.4
52-week High :  20.95 Low :  5.69
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ HSDT ] has closed above bottom band by 14.1%. Bollinger Bands are 62.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.52 - 6.55 6.55 - 6.57
Low: 6.25 - 6.29 6.29 - 6.33
Close: 6.3 - 6.36 6.36 - 6.42
Company Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Headline News

Thu, 09 Nov 2023
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results - Yahoo Finance

Mon, 06 Nov 2023
John Fetterman says Gavin Newsom is lowkey running for president against Joe Biden but doesn't have 'the guts' to announce it and go all in - Yahoo Canada Shine On

Mon, 06 Nov 2023
Helius Medical Technologies, Inc. Announces Study Results ... - BioSpace

Thu, 02 Nov 2023
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024 - Yahoo Finance

Fri, 20 Oct 2023
3 Metaverse Stocks to Invest in for the Internet's Next Evolution - InvestorPlace

Thu, 12 Oct 2023
Helius Medical Technologies, Inc. Receives Letter of Intent from the ... - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out 0 (M)
Shares Float 1 (M)
Held by Insiders 651840 (%)
Held by Institutions 0 (%)
Shares Short 79 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.251e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -2 %
Return on Assets (ttm) 93.7 %
Return on Equity (ttm) -57.3 %
Qtrly Rev. Growth 792000 %
Gross Profit (p.s.) -21.96
Sales Per Share -129.13
EBITDA (p.s.) 263415
Qtrly Earnings Growth -11.9 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -11 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.05
Price to Cash Flow 1.77
Stock Dividends
Dividend 0
Forward Dividend 67230
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android